In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Astria Therapeutics Inc (NASDAQ: ATXS) closed the day trading at $7.79 up 5.70% from the previous closing price of $7.37. In other words, the price has increased by $5.70 from its previous closing price. On the day, 0.57 million shares were traded. ATXS stock price reached its highest trading level at $7.87 during the session, while it also had its lowest trading level at $7.29.
Ratios:
For a better understanding of ATXS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.38 and its Current Ratio is at 22.38. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on July 29, 2024, initiated with a Buy rating and assigned the stock a target price of $35.
On March 28, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.
PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 439622400 and an Enterprise Value of 207100368.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.71, which has changed by 0.036568165 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $6.94. The 50-Day Moving Average of the stock is -20.33%, while the 200-Day Moving Average is calculated to be -25.09%.
Shares Statistics:
Over the past 3-months, ATXS traded about 300.29K shares per day on average, while over the past 10 days, ATXS traded about 320380 shares per day. A total of 56.43M shares are outstanding, with a floating share count of 45.38M. Insiders hold about 19.58% of the company’s shares, while institutions hold 87.22% stake in the company. Shares short for ATXS as of 1735603200 were 3365629 with a Short Ratio of 11.21, compared to 1732838400 on 3145785. Therefore, it implies a Short% of Shares Outstanding of 3365629 and a Short% of Float of 6.1899999999999995.
